TickerGuard
Buy Day today: Neutral (61) Mixed market breadth · no major macro event
ONC

BeiGene, Ltd.

Healthcare · Biotechnology

420.00$ -0.9% vs. previous close Closing price · As of: Nov 11, 2026

Ownership

Ownership Structure

Who owns BeiGene, Ltd. (ONC)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 77.2% of the shares are freely tradable; institutional investors hold 33.0%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 33.0%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 17.3%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 77.2%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 2.2%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 105Mio.

Largest Shareholders

Institutions

Institutions ONC
Name Stake (%) Shares Change (%) Date
Baker Bros Advisors LP 7.71 8,801,567 +0.0 06/30/2026
PRIMECAP Management Company 4.38 5,007,931 +0.7 06/30/2026
Capital Research & Mgmt Co - Division 3 3.69 4,210,221 +1.2 06/30/2026
FMR Inc 2.17 2,478,527 -32.9 06/30/2026
Capital World Investors 1.97 2,249,582 +38.6 06/30/2026
Citadel Advisors Llc 1.25 1,425,517 +38.1 06/30/2026

Funds

Funds ONC
Name Stake (%) Shares Change (%) Date
American Funds New Perspective A 2.66 3,035,500 +13.9 09/30/2026
Vanguard PRIMECAP Inv 2.01 2,301,422 -2.0 09/30/2026
Vanguard Capital Opportunity Inv 1.02 1,170,071 -1.0 09/30/2026
American Funds New Economy A 0.85 972,969 +97.9 09/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Nov 6, 2026 Ball Titus B. Principal Accounting Officer Sell 26 406.34 10,565
Nov 6, 2026 Ball Titus B. Principal Accounting Officer Sell 1,533 405.55 621,712
Nov 6, 2026 Ball Titus B. Principal Accounting Officer Other 679 159.03 107,981
Nov 6, 2026 Ball Titus B. Principal Accounting Officer Other 880 207.55 182,644
Nov 5, 2026 Lee Chan Henry SVP, General Counsel Sell 455 402.00 182,910
Nov 5, 2026 Lee Chan Henry SVP, General Counsel Sell 660 400.00 264,000
Oct 27, 2026 Wang Xiaodong Director Sell 6,903 366.22 2,528,020
Oct 27, 2026 Wang Xiaodong Director Sell 3,965 365.43 1,448,927
Oct 27, 2026 Wang Xiaodong Director Sell 2,841 363.95 1,033,980
Oct 27, 2026 Wang Xiaodong Director Sell 8,148 363.24 2,959,696
Oct 27, 2026 Wang Xiaodong Director Sell 2,331 362.35 844,639
Oct 27, 2026 Wang Xiaodong Director Sell 320 360.64 115,404
Oct 27, 2026 Wang Xiaodong Director Sell 1,280 359.72 460,444
Oct 27, 2026 Wang Xiaodong Director Sell 1,681 358.75 603,052
Oct 27, 2026 Wang Xiaodong Director Sell 1,239 357.54 442,990
Oct 27, 2026 Wang Xiaodong Director Sell 1,440 355.62 512,087
Oct 27, 2026 Wang Xiaodong Director Sell 880 355.56 312,892
Oct 27, 2026 Wang Xiaodong Director Other 31,028 36.90 1,144,933
Oct 13, 2026 Wang Xiaodong Director Sell 1,260 353.24 445,078
Oct 13, 2026 Wang Xiaodong Director Sell 6,558 352.57 2,312,148
Oct 13, 2026 Wang Xiaodong Director Sell 5,681 351.40 1,996,280
Oct 13, 2026 Wang Xiaodong Director Sell 10,361 350.47 3,631,262
Oct 13, 2026 Wang Xiaodong Director Sell 7,167 349.56 2,505,306
Oct 13, 2026 Wang Xiaodong Director Other 31,027 36.90 1,144,896
Sep 30, 2026 Lee Chan Henry SVP, General Counsel Sell 1,115 375.00 418,125
Sep 28, 2026 Wang Xiaodong Director Sell 738 367.23 271,012
Sep 28, 2026 Wang Xiaodong Director Sell 14,525 366.58 5,324,550
Sep 28, 2026 Wang Xiaodong Director Sell 2,047 365.85 748,891
Sep 28, 2026 Wang Xiaodong Director Sell 3,419 364.07 1,244,747
Sep 28, 2026 Wang Xiaodong Director Sell 3,499 363.10 1,270,485
Sep 28, 2026 Wang Xiaodong Director Sell 4,239 362.17 1,535,228
Sep 28, 2026 Wang Xiaodong Director Sell 2,241 361.05 809,120
Sep 28, 2026 Wang Xiaodong Director Sell 40 359.16 14,366
Sep 28, 2026 Wang Xiaodong Director Sell 120 358.71 43,045
Sep 28, 2026 Wang Xiaodong Director Sell 160 356.97 57,115
Sep 28, 2026 Wang Xiaodong Director Other 31,028 36.90 1,144,933
Sep 8, 2026 Wang Xiaodong Director Sell 6,278 351.25 2,205,174
Sep 8, 2026 Wang Xiaodong Director Sell 6,569 350.27 2,300,951
Sep 8, 2026 Wang Xiaodong Director Sell 10,688 349.28 3,733,141
Sep 8, 2026 Wang Xiaodong Director Sell 7,492 348.31 2,609,573
Sep 8, 2026 Wang Xiaodong Director Other 31,027 36.90 1,144,896
Sep 8, 2026 Wang Xiaodong Director Sell 1,721 348.01 598,930
Sep 8, 2026 Wang Xiaodong Director Sell 1,517 347.39 526,993
Sep 8, 2026 Wang Xiaodong Director Sell 2,841 346.16 983,433
Sep 8, 2026 Wang Xiaodong Director Sell 1,181 345.38 407,897
Sep 1, 2026 Ball Titus B. Principal Accounting Officer Sell 132 355.86 46,974
Aug 25, 2026 Wu Xiaobin President and COO Sell 280 380.00 106,400
Aug 12, 2026 Oyler John Chief Executive Officer Sell 14,102 359.12 5,064,252
Aug 12, 2026 Oyler John Chief Executive Officer Sell 20,899 358.41 7,490,448
Aug 12, 2026 Oyler John Chief Executive Officer Sell 15,396 357.63 5,506,147

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: November 11, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?